Tranquil Immune

Curated by Signal

Developer of technology for developing auto-immune disease therapeutics

Overview

Developer of technology for developing auto-immune disease therapeutics. It offers T-cell Silencer technology by suppresses the pathogenic T-cell activation for clinical treatment of Multiple Sclerosis and Crohn’s disease.

Key facts

Founded: 2021
Headquarters: Bonn, Germany
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

GxP brain
Clinical software development for pharma companies
Health TechnologyBerlin, Germany
DOG1
Online platform offering nutritional supplements for dogs
Health TechnologyGutersloh, Germany
alley
Mobile-based application for osteoarthritis treatment
Health TechnologyCologne, Germany

About Tranquil Immune

What does Tranquil Immune do?

Developer of technology for developing auto-immune disease therapeutics.

Where is Tranquil Immune headquartered?

Tranquil Immune is headquartered in Bonn, Germany.

When was Tranquil Immune founded?

Tranquil Immune was founded in 2021.

Which sector is Tranquil Immune in?

Tranquil Immune operates in Health Technology.

Who are Tranquil Immune's competitors?

Companies similar to Tranquil Immune include GxP brain, DOG1, and alley.